Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1
- PMID: 12807725
- DOI: 10.1093/carcin/bgg078
Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1
Abstract
Cigarette smoke (CS) is a major cause of a variety of malignancies including cancers of the larynx, oral cavity and pharynx, esophagus, pancreas, kidney, bladder and lung. The signal transduction pathway that mediates the effects of CS is not well understood but nuclear factor-kappa B (NF-kappaB) is probably involved. The gas phase of CS contains free radicals such as superoxide radicals, hydroxyl radicals and hydrogen peroxide, which potentially can activate NF-kappaB. Benzo[a]pyrene, another potent carcinogen of CS, can also activate NF-kappaB, but by an as yet unknown mechanism. Various other agents that activate NF-kappaB are either tumor initiators or tumor promoters, and NF-kappaB activation can block apoptosis, promote proliferation and mediate tumorigenesis. Therefore, NF-kappaB is an ideal target for preventing CS-induced lung carcinogenesis. Thus, agents that abrogate NF-kappaB activation have the potential to suppress lung carcinogenesis. Because curcumin, a diferuloylmethane, is anticarcinogenic, we investigated the effect of this phytochemical on CS-induced NF-kappaB activation and NF-kappaB-regulated gene expression in human non-small cell lung carcinoma cells. Exposure of cells to CS induced persistent activation of NF-kappaB, and pre-treatment with curcumin abolished the CS-induced DNA-binding of NF-kappaB, IkappaBalpha kinase activation, IkBalpha phosphorylation and degradation, p65 nuclear translocation and CS-induced NF-kappaB-dependent reporter gene expression. The inhibition of NF-kappaB activation correlated with suppression of CS-induced NF-kappaB-dependent cyclin D1, cyclooxygenase-2 and matrix metalloproteinase-9 expression. Overall our results indicate that CS-induced NF-kappaB activation and NF-kappaB-regulated gene expression in human non-small cell lung carcinoma cells is suppressed by curcumin through suppression of IkappaBalpha kinase.
Similar articles
-
Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.Cancer Res. 2004 Jul 15;64(14):5004-12. doi: 10.1158/0008-5472.CAN-04-0206. Cancer Res. 2004. PMID: 15256475
-
Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.Cancer Res. 2003 Aug 1;63(15):4375-83. Cancer Res. 2003. PMID: 12907607
-
Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.Mol Pharmacol. 2006 Jan;69(1):195-206. doi: 10.1124/mol.105.017400. Epub 2005 Oct 11. Mol Pharmacol. 2006. PMID: 16219905
-
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation.Mutat Res. 2001 Sep 1;480-481:243-68. doi: 10.1016/s0027-5107(01)00183-x. Mutat Res. 2001. PMID: 11506818 Review.
-
Molecular mechanisms of curcumins suppressing effects on tumorigenesis, angiogenesis and metastasis, focusing on NF-κB pathway.Cytokine Growth Factor Rev. 2016 Apr;28:21-9. doi: 10.1016/j.cytogfr.2015.12.004. Epub 2016 Jan 2. Cytokine Growth Factor Rev. 2016. PMID: 26774676 Review.
Cited by
-
Curcumin: A Potential Weapon in the Prevention and Treatment of Head and Neck Cancer.ACS Pharmacol Transl Sci. 2024 Oct 14;7(11):3394-3418. doi: 10.1021/acsptsci.4c00518. eCollection 2024 Nov 8. ACS Pharmacol Transl Sci. 2024. PMID: 39539276 Review.
-
Air-Pollution-Mediated Microbial Dysbiosis in Health and Disease: Lung-Gut Axis and Beyond.J Xenobiot. 2024 Oct 21;14(4):1595-1612. doi: 10.3390/jox14040086. J Xenobiot. 2024. PMID: 39449427 Free PMC article. Review.
-
Evaluation of Cross-Talk and Alleviate Potential of Cytotoxic Factors Induced by Deoxynivalenol in IPEC-J2 Cells Interference with Curcumin.Int J Mol Sci. 2024 Jun 26;25(13):6984. doi: 10.3390/ijms25136984. Int J Mol Sci. 2024. PMID: 39000093 Free PMC article.
-
Inflammation and cancer: friend or foe?Front Pharmacol. 2024 May 10;15:1385479. doi: 10.3389/fphar.2024.1385479. eCollection 2024. Front Pharmacol. 2024. PMID: 38799159 Free PMC article. Review.
-
Nuclear factor kappa B expression in non-small cell lung cancer.Biomed Pharmacother. 2023 Nov;167:115459. doi: 10.1016/j.biopha.2023.115459. Epub 2023 Sep 15. Biomed Pharmacother. 2023. PMID: 37716117 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
